Preventing HPV-related cervical and throat cancers in people with HIV in Brazil, Mexico, and Puerto Rico
Partnership for Prevention of HPV-Associated Cancers in People Living with HIV: Brazil, Mexico, and Puerto Rico
This partnership is working to prevent HPV-related cervical and oropharyngeal (throat) cancers in people living with HIV across Brazil, Mexico, and Puerto Rico.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Weill Medical Coll of Cornell Univ NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-11400887 on NIH RePORTER |
What this research studies
If I join, I'll be part of clinical trials run by sites in Brazil, Mexico, and Puerto Rico that test ways to prevent HPV-linked cervical and oropharyngeal cancers in people living with HIV. The program brings together experienced HPV and HIV researchers and may include screening, vaccination, and other prevention strategies tailored for people with HIV. Local investigators will be trained and sites will share data and methods to run high-quality, coordinated studies across countries. The goal is to lower cancer illness and deaths among people living with HIV and contribute to broader cervical cancer elimination efforts.
Who could benefit from this research
Good fit: Ideal participants are people living with HIV who are eligible for prevention-focused clinical trials at participating sites in Brazil, Mexico, or Puerto Rico.
Not a fit: People without HIV, those who cannot access participating sites or live outside the covered regions, and patients with advanced HPV-related cancer may not directly benefit from these prevention trials.
Why it matters
Potential benefit: If successful, the work could reduce rates of cervical and oropharyngeal cancers and improve prevention options for people living with HIV.
How similar studies have performed: HPV vaccination and cervical screening have reduced cancer in general populations, but prevention approaches specifically tailored to people living with HIV and for oropharyngeal cancer are less established and are being addressed by this partnership.
Where this research is happening
New York, United States
- Weill Medical Coll of Cornell Univ — New York, United States (Active)
Researchers
- Principal investigator: Ellsworth, Grant B. — Weill Medical Coll of Cornell Univ
- Study coordinator: Ellsworth, Grant B.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.